Skip to main navigation Skip to search Skip to main content

Bismuth complexes inhibit the SARS coronavirus

  • Nan Yang
  • , Julian A. Tanner
  • , Bo-Jian Zheng
  • , Rory M. Watt
  • , Ming-Liang He
  • , Lin-Yu Lu
  • , Jie-Qing Jiang
  • , Ka-To Shum
  • , Yong-Ping Lin
  • , Kin-Ling Wong
  • , Marie C. M. Lin
  • , Hsiang-Fu Kung
  • , Hongzhe Sun
  • , Jian-Dong Huang

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

Abstract

Hold tight: Bismuth complexes including ranitidine bismuth citrate effectively inhibit the nucleoside triphosphate hydrolase and DNA unwinding activities of the SARS coronavirus (SCV) helicase and dramatically reduce SCV replication levels in infected cells. This suggests that bismuth-based drugs should be further evaluated for the treatment of SCV infections in vivo. ss = single-stranded DNA, ds = duplex DNA. (Figure Presented). © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.
Original languageEnglish
Pages (from-to)6464-6468
JournalAngewandte Chemie - International Edition
Volume46
Issue number34
DOIs
Publication statusPublished - 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • Antiviral agents
  • Bismuth
  • Enzymes
  • Helical structures
  • SARS coronavirus

Fingerprint

Dive into the research topics of 'Bismuth complexes inhibit the SARS coronavirus'. Together they form a unique fingerprint.

Cite this